These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
319 related items for PubMed ID: 22262129
1. Twelve-week posttreatment follow-up to predict sustained virologic response for recurrent hepatitis C infection in liver recipients. Campos-Varela I, Castells L, Esteban JI, Bes M, Rodríguez-Frías F, Sapisochin G, Allende H, Charco R, Esteban R. Transplantation; 2012 Feb 27; 93(4):450-3. PubMed ID: 22262129 [Abstract] [Full Text] [Related]
2. Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin. Martinot-Peignoux M, Stern C, Maylin S, Ripault MP, Boyer N, Leclere L, Castelnau C, Giuily N, El Ray A, Cardoso AC, Moucari R, Asselah T, Marcellin P. Hepatology; 2010 Apr 27; 51(4):1122-6. PubMed ID: 20069649 [Abstract] [Full Text] [Related]
3. Recurrent hepatitis C after liver transplantation: on-treatment prediction of response to peginterferon/ribavirin therapy. Hanouneh IA, Miller C, Aucejo F, Lopez R, Quinn MK, Zein NN. Liver Transpl; 2008 Jan 27; 14(1):53-8. PubMed ID: 18161839 [Abstract] [Full Text] [Related]
10. Prediction of sustained virological response in liver transplant recipients with recurrent hepatitis C virus following combination pegylated interferon alfa-2b and ribavirin therapy using tissue hepatitis C virus reverse transcriptase polymerase chain reaction testing. Neff GW, O'Brien CB, Cirocco R, Montalbano M, de Medina M, Ruiz P, Khaled AS, Bejarano PA, Safdar K, Hill MA, Tzakis AG, Schiff ER. Liver Transpl; 2004 May 27; 10(5):595-8. PubMed ID: 15108250 [Abstract] [Full Text] [Related]
11. Short duration treatment in genotype 1 chronic hepatitis C patients with rapid virologic response to pegylated interferon plus ribavirin. Bonardi R, Tabone M, Manca A, Pellicano R, Ciancio A, Rizzetto M. Biomed Pharmacother; 2011 Jul 27; 65(4):303-6. PubMed ID: 21723079 [Abstract] [Full Text] [Related]